Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

PD-L1 Expression, Tumor Mutational Burden, and Response to Immunotherapy in Patients with MET exon 14 Altered Lung Cancers.

Sabari JK, Leonardi GC, Shu CA, Umeton R, Montecalvo J, Ni A, Chen R, Dienstag J, Mrad C, Bergagnini I, Lai WV, Offin MD, Arbour KC, Plodkowski AJ, Halpenny DF, Paik PK, Li BT, Riely GJ, Kris MG, Rudin CM, Sholl LM, Nishino M, Hellmann MD, Rekhtman N, Awad MM, Drilon A.

Ann Oncol. 2018 Aug 27. doi: 10.1093/annonc/mdy334. [Epub ahead of print]

PMID:
30165371
2.

Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer.

Arbour KC, Mezquita L, Long N, Rizvi H, Auclin E, Ni A, Martínez-Bernal G, Ferrara R, Lai WV, Hendriks LEL, Sabari JK, Caramella C, Plodkowski AJ, Halpenny D, Chaft JE, Planchard D, Riely GJ, Besse B, Hellmann MD.

J Clin Oncol. 2018 Oct 1;36(28):2872-2878. doi: 10.1200/JCO.2018.79.0006. Epub 2018 Aug 20.

PMID:
30125216
3.

Next-generation sequencing based detection of germline and somatic alterations in a patient with four metachronous primary tumors.

Martin M, Sabari JK, Turashvili G, Halpenny DF, Rizvi H, Shapnik N, Makker V.

Gynecol Oncol Rep. 2018 Apr 18;24:94-98. doi: 10.1016/j.gore.2018.04.004. eCollection 2018 May.

4.

Response to ERBB3-Directed Targeted Therapy in NRG1-Rearranged Cancers.

Drilon A, Somwar R, Mangatt BP, Edgren H, Desmeules P, Ruusulehto A, Smith RS, Delasos L, Vojnic M, Plodkowski AJ, Sabari J, Ng K, Montecalvo J, Chang J, Tai H, Lockwood WW, Martinez V, Riely GJ, Rudin CM, Kris MG, Arcila ME, Matheny C, Benayed R, Rekhtman N, Ladanyi M, Ganji G.

Cancer Discov. 2018 Jun;8(6):686-695. doi: 10.1158/2159-8290.CD-17-1004. Epub 2018 Apr 2.

PMID:
29610121
5.

Relevance of genetic alterations in squamous and small cell lung cancer.

Sabari JK, Paik PK.

Ann Transl Med. 2017 Sep;5(18):373. doi: 10.21037/atm.2017.06.72. Review.

6.

Pulmonary large cell neuroendocrine carcinoma with adenocarcinoma-like features: napsin A expression and genomic alterations.

Rekhtman N, Pietanza CM, Sabari J, Montecalvo J, Wang H, Habeeb O, Kadota K, Adusumilli P, Rudin CM, Ladanyi M, Travis WD, Joubert P.

Mod Pathol. 2018 Jan;31(1):111-121. doi: 10.1038/modpathol.2017.110. Epub 2017 Sep 8.

7.

Targeting RET-rearranged lung cancers with multikinase inhibitors.

Sabari JK, Siau ED, Drilon A.

Oncoscience. 2017 Apr 14;4(3-4):23-24. doi: 10.18632/oncoscience.345. eCollection 2017 Mar. No abstract available.

8.

Unravelling the biology of SCLC: implications for therapy.

Sabari JK, Lok BH, Laird JH, Poirier JT, Rudin CM.

Nat Rev Clin Oncol. 2017 Sep;14(9):549-561. doi: 10.1038/nrclinonc.2017.71. Epub 2017 May 23. Review.

9.

Immunophenotypic evidence for reactive polyclonal marrow plasmacytosis in multiple myeloma patients receiving lenalidomide maintenance.

Hassoun H, Roshal M, Sabari J, Nguyen J, Gao Q, Devlin SM, Landau H, Lendvai N, Chung DJ, Lesokhin AM, Korde N, Mailankody S, Dogan A, Giralt SA, Landgren CO.

Leuk Lymphoma. 2017 Dec;58(12):2962-2965. doi: 10.1080/10428194.2017.1312382. Epub 2017 May 9. No abstract available.

PMID:
28482750
10.

The activity, safety, and evolving role of brigatinib in patients with ALK-rearranged non-small cell lung cancers.

Sabari JK, Santini FC, Schram AM, Bergagnini I, Chen R, Mrad C, Lai WV, Arbour KC, Drilon A.

Onco Targets Ther. 2017 Apr 6;10:1983-1992. doi: 10.2147/OTT.S109295. eCollection 2017. Review.

11.

Changing the Therapeutic Landscape in Non-small Cell Lung Cancers: the Evolution of Comprehensive Molecular Profiling Improves Access to Therapy.

Sabari JK, Santini F, Bergagnini I, Lai WV, Arbour KC, Drilon A.

Curr Oncol Rep. 2017 Apr;19(4):24. doi: 10.1007/s11912-017-0587-4. Review.

PMID:
28303491
12.

PS01.24: Clinical Outcomes of Patients with Pulmonary Large Cell Neuroendocrine Carcinoma Characterized by Next-Generation Sequencing: Topic: Medical Oncology.

Sabari J, Rudin C, Rekhtman N.

J Thorac Oncol. 2016 Nov;11(11S):S283. doi: 10.1016/j.jtho.2016.09.059. Epub 2016 Oct 28. No abstract available.

13.

Have adjuvant tyrosine kinase inhibitors lost their shine?

Sabari JK, Chaft JE.

Ann Transl Med. 2016 Aug;4(15):285. doi: 10.21037/atm.2016.07.18.

14.

Clinical outcomes with pemetrexed-based systemic therapies in RET-rearranged lung cancers.

Drilon A, Bergagnini I, Delasos L, Sabari J, Woo KM, Plodkowski A, Wang L, Hellmann MD, Joubert P, Sima CS, Smith R, Somwar R, Rekhtman N, Ladanyi M, Riely GJ, Kris MG.

Ann Oncol. 2016 Jul;27(7):1286-91. doi: 10.1093/annonc/mdw163. Epub 2016 Apr 7.

15.

Impact of wheelchair seat height on neck and shoulder range of motion during functional task performance.

Sabari J, Shea M, Chen L, Laurenceau A, Leung E.

Assist Technol. 2016 Fall;28(3):183-9. doi: 10.1080/10400435.2016.1140692.

PMID:
26853925
16.

Activity engagement and health quality of life in people with Parkinson's disease.

Sabari JS, Ortiz D, Pallatto K, Yagerman J, Glazman S, Bodis-Wollner I.

Disabil Rehabil. 2015;37(16):1411-5. doi: 10.3109/09638288.2014.972588. Epub 2014 Oct 21.

PMID:
25332087
17.

Rasch analysis of a new hierarchical scoring system for evaluating hand function on the motor assessment scale for stroke.

Sabari JS, Woodbury M, Velozo CA.

Stroke Res Treat. 2014;2014:730298. doi: 10.1155/2014/730298. Epub 2014 Aug 7.

18.

Fibronectin matrix assembly suppresses dispersal of glioblastoma cells.

Sabari J, Lax D, Connors D, Brotman I, Mindrebo E, Butler C, Entersz I, Jia D, Foty RA.

PLoS One. 2011;6(9):e24810. doi: 10.1371/journal.pone.0024810. Epub 2011 Sep 30.

19.

Assessing arm and hand function after stroke: a validity test of the hierarchical scoring system used in the motor assessment scale for stroke.

Sabari JS, Lim AL, Velozo CA, Lehman L, Kieran O, Lai JS.

Arch Phys Med Rehabil. 2005 Aug;86(8):1609-15.

PMID:
16084815
20.

Constraint-induced motor relearning after stroke: a naturalistic case report.

Sabari JS, Kane L, Flanagan SR, Steinberg A.

Arch Phys Med Rehabil. 2001 Apr;82(4):524-8.

PMID:
11295016
21.

Reflections upon rehabilitation by members of a community based stroke club.

Sabari JS, Meisler J, Silver E.

Disabil Rehabil. 2000 May 10;22(7):330-6.

PMID:
10877487
22.

Goniometric assessment of shoulder range of motion: comparison of testing in supine and sitting positions.

Sabari JS, Maltzev I, Lubarsky D, Liszkay E, Homel P.

Arch Phys Med Rehabil. 1998 Jun;79(6):647-51.

PMID:
9630143
23.

Occupational therapy after stroke: are we providing the right services at the right time?

Sabari JS.

Am J Occup Ther. 1998 Apr;52(4):299-302. No abstract available.

PMID:
9544357
24.

A competency-based training program in early intervention.

Hinojosa J, Moore DS, Sabari JS, Doctor RG.

Am J Occup Ther. 1994 Apr;48(4):361-6.

PMID:
8059870
25.

Motor learning concepts applied to activity-based intervention with adults with hemiplegia.

Sabari JS.

Am J Occup Ther. 1991 Jun;45(6):523-30. Review.

PMID:
2063941
26.

Professional socialization: implications for occupational therapy education.

Sabari JS.

Am J Occup Ther. 1985 Feb;39(2):96-102.

PMID:
3976829
27.

Purposeful activities. A position paper.

Hinojosa J, Sabari J, Rosenfeld MS, Shapiro D.

Am J Occup Ther. 1983 Dec;37(12):805-6. No abstract available.

PMID:
6666767
28.

Supplemental Content

Loading ...
Support Center